ELV Insider Trading

Insider Ownership Percentage: 0.29%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $24,314,910.69

Elevance Health Insider Trading History Chart

This chart shows the insider buying and selling history at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.95MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10M$0$10MTotal Insider BuyingTotal Insider Selling

Elevance Health Share Price & Price History

Current Price: $413.41
Price Change: Price Decrease of -8.27 (-1.96%)
As of 04/28/2025 04:59 PM ET

This chart shows the closing price history over time for ELV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$413.41Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Elevance Health (NYSE:ELV)

89.24% of Elevance Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$902Mbought$254MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20B$0$20BTotal InflowsTotal Outflows
Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More on Elevance Health

Today's Range

Now: $413.41
Low: $409.71
High: $427.54

50 Day Range

MA: $420.43
Low: $384.91
High: $452.70

52 Week Range

Now: $413.41
Low: $362.21
High: $567.26

Volume

1,534,501 shs

Average Volume

1,454,619 shs

Market Capitalization

$93.40 billion

P/E Ratio

16.14

Dividend Yield

1.62%

Beta

0.77

Who are the company insiders with the largest holdings of Elevance Health?

Elevance Health's top insider investors include:
  1. Gail Boudreaux (CEO)
  2. Felicia F Norwood (EVP)
  3. Mark Kaye (CFO)
  4. Charles Morgan Kendrick Jr (EVP)
  5. Robert L Dixon Jr (Director)
  6. Ramiro G Peru (Director)
  7. Ronald W Penczek (CAO)
Learn More about top insider investors at Elevance Health.

Who are the major institutional investors of Elevance Health?

Elevance Health's top institutional shareholders include:
  1. GAMMA Investing LLC — 0.65%
  2. Sumitomo Mitsui Trust Group Inc. — 0.38%
  3. Rhumbline Advisers — 0.21%
  4. KBC Group NV — 0.16%
  5. Canoe Financial LP — 0.14%
  6. DAVENPORT & Co LLC — 0.12%
Learn More about top institutional investors of Elevance Health stock.

Which major investors are selling Elevance Health stock?

During the previous quarter, ELV stock was sold by these institutional investors:
  1. Canoe Financial LP
  2. Assenagon Asset Management S.A.
  3. KBC Group NV
  4. Generate Investment Management Ltd
  5. Allspring Global Investments Holdings LLC
  6. Achmea Investment Management B.V.
  7. Robeco Institutional Asset Management B.V.
  8. Lmcg Investments LLC
Within the previous year, company insiders that have sold Elevance Health company stock include:
  1. Gail Boudreaux (CEO)
  2. Felicia F Norwood (EVP)
  3. Mark Kaye (CFO)
  4. Charles Morgan Kendrick Jr (EVP)
  5. Robert L Dixon Jr (Director)
  6. Ramiro G Peru (Director)
Learn More investors selling Elevance Health stock.

Which major investors are buying Elevance Health stock?

During the previous quarter, ELV stock was acquired by institutional investors including:
  1. GAMMA Investing LLC
  2. Demars Financial Group LLC
  3. Perpetual Ltd
  4. Teacher Retirement System of Texas
  5. DAVENPORT & Co LLC
  6. Fulcrum Asset Management LLP
  7. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH
  8. QRG Capital Management Inc.